BR9611173A - Method for mobilizing ancestral hematopathic cells - Google Patents

Method for mobilizing ancestral hematopathic cells

Info

Publication number
BR9611173A
BR9611173A BR9611173A BR9611173A BR9611173A BR 9611173 A BR9611173 A BR 9611173A BR 9611173 A BR9611173 A BR 9611173A BR 9611173 A BR9611173 A BR 9611173A BR 9611173 A BR9611173 A BR 9611173A
Authority
BR
Brazil
Prior art keywords
hematopathic
mobilizing
ancestral
cells
mobilizing ancestral
Prior art date
Application number
BR9611173A
Other languages
Portuguese (pt)
Inventor
Andrew Garrison King
Louis Martins Pelus
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of BR9611173A publication Critical patent/BR9611173A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52Cytokines; Lymphokines; Interferons
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52Cytokines; Lymphokines; Interferons
    • C07K14/521Chemokines
    • C07K14/522Alpha-chemokines, e.g. NAP-2, ENA-78, GRO-alpha/MGSA/NAP-3, GRO-beta/MIP-2alpha, GRO-gamma/MIP-2beta, IP-10, GCP-2, MIG, PBSF, PF-4, KC
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18Growth factors; Growth regulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19Cytokines; Lymphokines; Interferons
    • A61K38/193Colony stimulating factors [CSF]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475Growth factors; Growth regulators
    • C07K14/49Platelet-derived growth factor [PDGF]
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
BR9611173A 1995-10-24 1996-10-24 Method for mobilizing ancestral hematopathic cells BR9611173A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US54726295A 1995-10-24 1995-10-24
PCT/US1996/017074 WO1997015595A1 (en) 1995-10-24 1996-10-24 Method of mobilizing hematopoietic stem cells

Publications (1)

Publication Number Publication Date
BR9611173A true BR9611173A (en) 1999-03-30

Family

ID=24183989

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9611173A BR9611173A (en) 1995-10-24 1996-10-24 Method for mobilizing ancestral hematopathic cells

Country Status (14)

Country Link
EP (1) EP0866806A4 (en)
JP (1) JPH11512747A (en)
KR (1) KR19990066997A (en)
AR (1) AR004093A1 (en)
AU (1) AU712235B2 (en)
BR (1) BR9611173A (en)
CZ (1) CZ120298A3 (en)
HU (1) HUP9802531A3 (en)
NO (1) NO981818L (en)
NZ (1) NZ321789A (en)
PL (1) PL326364A1 (en)
TR (1) TR199800742T2 (en)
WO (1) WO1997015595A1 (en)
ZA (1) ZA968896B (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6391589B1 (en) 1994-08-23 2002-05-21 Human Genome Sciences, Inc. Human chemokine beta-10 mutant polypeptides
US6174995B1 (en) 1994-08-23 2001-01-16 Haodong Li Human chemokines, CKβ4 and CKβ10/MCP-4
US6458349B1 (en) 1995-06-02 2002-10-01 Human Genome Sciences, Inc. Chemokine β-4 polypeptides
US6042821A (en) * 1995-11-21 2000-03-28 Smithkline Beecham Corporation Method of treating sepsis with chemokines
US6290948B1 (en) * 1996-05-14 2001-09-18 Smithkline Beecham Corporation Method of treating sepsis and ARDS using chamohine beta-10
JP2001523727A (en) * 1997-11-26 2001-11-27 スミスクライン・ビーチャム・コーポレイション How to mobilize hematopoietic stem cells
AU780074B2 (en) * 1999-06-08 2005-02-24 Transgene S.A. Composition for implementing a cytotoxic, in particular an antitumoral or antiviral, treatment in a mammal
WO2002002132A1 (en) * 2000-06-30 2002-01-10 Smithkline Beecham Corporation Chemokine conjugates
JP3563366B2 (en) * 2001-05-07 2004-09-08 独立行政法人 科学技術振興機構 Protein multimers with unfolding activity on protein conformation
IL146970A0 (en) * 2001-12-06 2002-08-14 Yeda Res & Dev Migration of haematopoietic stem cells and progenitor cells to the liver
ATE518884T1 (en) 2002-05-01 2011-08-15 Human Genome Sciences Inc ANTIBODIES SPECIFICALLY BINDING TO CHEMOKIN BETA-4
AR084141A1 (en) 2010-11-19 2013-04-24 Imai Toshio ANTI-CCL20 NEUTRALIZING ANTIBODIES

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0713495T3 (en) * 1993-06-08 2004-03-08 Smithkline Beecham Corp Methods for enhancing the biological activity of chemokines
GB9426012D0 (en) * 1994-12-22 1995-02-22 British Biotech Pharm Mobilisation of haematopoietic cells
GB9517014D0 (en) * 1995-08-19 1995-10-25 British Biotech Pharm Haematopoietic recovery

Also Published As

Publication number Publication date
HUP9802531A2 (en) 1999-02-01
HUP9802531A3 (en) 2001-08-28
AU7520996A (en) 1997-05-15
AR004093A1 (en) 1998-09-30
EP0866806A1 (en) 1998-09-30
EP0866806A4 (en) 2002-01-09
NO981818L (en) 1998-06-17
AU712235B2 (en) 1999-11-04
KR19990066997A (en) 1999-08-16
MX9803217A (en) 1998-09-30
WO1997015595A1 (en) 1997-05-01
CZ120298A3 (en) 1998-09-16
JPH11512747A (en) 1999-11-02
TR199800742T2 (en) 1998-08-21
ZA968896B (en) 1997-04-24
NO981818D0 (en) 1998-04-23
NZ321789A (en) 2000-07-28
PL326364A1 (en) 1998-09-14

Similar Documents

Publication Publication Date Title
DE69617372D1 (en) Data recording - / - reproduction method
BR9508190A (en) Method for making prepreg
IS4828A (en) Process for producing N-acetyl-D-glucosamine
FI950419A0 (en) data Transfer method
KR970006253A (en) Hydrocarbon Production Method
FI945844A (en) Data Transfer method
DE69520558D1 (en) HALOGENING PROCESS
NO963228D0 (en) Scaling procedure
NO970726D0 (en) Test method
ID20274A (en) PROCESS FOR PRODUCING DIAMINA
DE69514851D1 (en) Interatomic measurement method
BR9611173A (en) Method for mobilizing ancestral hematopathic cells
ID18898A (en) PROCESS FOR SUBSTITUTED PYRIDINE
DE69507032D1 (en) CHLORHYDRINE PROCESS
NO972239D0 (en) New replication process
MA24472A1 (en) PROCESS
BR9408521A (en) Method for synthesizing gamma-pyrones
MA24470A1 (en) PROCESS
ID15862A (en) PROCESS
BR9611040A (en) Manufacturing method for 1,1,1,3,3-pentafluorpropane
KR970006291A (en) Method for producing substituted aminocarbonyltriazolinone
FI955856A (en) Method for decarbonylating sugars
FI931051A (en) method Description
KR960012547A (en) Device simulation method
ATA141894A (en) DEVICE FOR PRODUCING NODES

Legal Events

Date Code Title Description
EG Technical examination (opinion): publication of technical examination (opinion)
FC Decision: refusal